Kuwait · Delayed Price · Currency is KWD · Price in KWF KWSE:NIH Statistics
Total Valuation
KWSE:NIH has a market cap or net worth of KWD 36.11 million. The enterprise value is 36.74 million.
| Market Cap | 36.11M |
| Enterprise Value | 36.74M |
Important Dates
The last earnings date was Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | Jun 23, 2026 |
Share Statistics
KWSE:NIH has 245.64 million shares outstanding. The number of shares has increased by 1.20% in one year.
| Current Share Class | 245.64M |
| Shares Outstanding | 245.64M |
| Shares Change (YoY) | +1.20% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.55% |
| Owned by Institutions (%) | n/a |
| Float | 154.24M |
Valuation Ratios
The trailing PE ratio is 38.69.
| PE Ratio | 38.69 |
| Forward PE | n/a |
| PS Ratio | 6.64 |
| PB Ratio | 0.74 |
| P/TBV Ratio | 0.84 |
| P/FCF Ratio | 10.77 |
| P/OCF Ratio | 10.76 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.69, with an EV/FCF ratio of 10.96.
| EV / Earnings | 39.26 |
| EV / Sales | 6.76 |
| EV / EBITDA | 36.69 |
| EV / EBIT | 42.42 |
| EV / FCF | 10.96 |
Financial Position
The company has a current ratio of 5.18, with a Debt / Equity ratio of 0.05.
| Current Ratio | 5.18 |
| Quick Ratio | 4.78 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 2.32 |
| Debt / FCF | 0.69 |
| Interest Coverage | 3.90 |
Financial Efficiency
Return on equity (ROE) is 1.94% and return on invested capital (ROIC) is 1.96%.
| Return on Equity (ROE) | 1.94% |
| Return on Assets (ROA) | 0.98% |
| Return on Invested Capital (ROIC) | 1.96% |
| Return on Capital Employed (ROCE) | 1.63% |
| Weighted Average Cost of Capital (WACC) | 6.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.10 |
| Inventory Turnover | 3.73 |
Taxes
In the past 12 months, KWSE:NIH has paid 3,661 in taxes.
| Income Tax | 3,661 |
| Effective Tax Rate | 0.39% |
Stock Price Statistics
The stock price has increased by +4.55% in the last 52 weeks. The beta is 0.41, so KWSE:NIH's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +4.55% |
| 50-Day Moving Average | 0.14 |
| 200-Day Moving Average | 0.14 |
| Relative Strength Index (RSI) | 47.39 |
| Average Volume (20 Days) | 9,338,146 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KWSE:NIH had revenue of KWD 5.44 million and earned 935,780 in profits. Earnings per share was 0.00.
| Revenue | 5.44M |
| Gross Profit | 2.55M |
| Operating Income | 866,216 |
| Pretax Income | 946,488 |
| Net Income | 935,780 |
| EBITDA | 1.00M |
| EBIT | 866,216 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 7.06 million in cash and 2.33 million in debt, with a net cash position of 4.74 million or 0.02 per share.
| Cash & Cash Equivalents | 7.06M |
| Total Debt | 2.33M |
| Net Cash | 4.74M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 48.54M |
| Book Value Per Share | 0.18 |
| Working Capital | 7.72M |
Cash Flow
In the last 12 months, operating cash flow was 3.35 million and capital expenditures -3,035, giving a free cash flow of 3.35 million.
| Operating Cash Flow | 3.35M |
| Capital Expenditures | -3,035 |
| Depreciation & Amortization | 135,252 |
| Net Borrowing | -202,015 |
| Free Cash Flow | 3.35M |
| FCF Per Share | 0.01 |
Margins
Gross margin is 46.96%, with operating and profit margins of 15.93% and 17.21%.
| Gross Margin | 46.96% |
| Operating Margin | 15.93% |
| Pretax Margin | 17.40% |
| Profit Margin | 17.21% |
| EBITDA Margin | 18.42% |
| EBIT Margin | 15.93% |
| FCF Margin | 61.62% |
Dividends & Yields
This stock pays an annual dividend of 0.00, which amounts to a dividend yield of 1.34%.
| Dividend Per Share | 0.00 |
| Dividend Yield | 1.34% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 2.57% |
| Buyback Yield | -1.20% |
| Shareholder Yield | 0.14% |
| Earnings Yield | 2.59% |
| FCF Yield | 9.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 5, 2025. It was a forward split with a ratio of 1.06.
| Last Split Date | Aug 5, 2025 |
| Split Type | Forward |
| Split Ratio | 1.06 |
Scores
KWSE:NIH has an Altman Z-Score of 3.62 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.62 |
| Piotroski F-Score | 6 |